Vor Biopharma (VOR) Total Non-Current Liabilities (2024 - 2026)

Vor Biopharma (VOR) has 3 years of Total Non-Current Liabilities data on file, last reported at $18.7 million in Q1 2026.

• On a quarterly basis, Total Non-Current Liabilities changed N/A year-over-year to $18.7 million in Q1 2026; TTM through Mar 2026 was $18.7 million, a N/A change from a year earlier, with the FY2025 full-year figure at $27.9 million, down 39.67% from the prior year.
• Total Non-Current Liabilities for Q1 2026 stood at $18.7 million, down from $27.9 million in the prior quarter.
• Over the last five years, Total Non-Current Liabilities for VOR reached as high as $58.8 million in Q2 2025 and fell as low as $18.7 million in Q1 2026.
• Historically, Total Non-Current Liabilities has averaged $34.6 million across 3 years, with a median of $27.9 million in 2025.
• On a YoY basis, Total Non-Current Liabilities climbed as much as 39.67% in 2025 and fell as far as 39.67% in 2025.
• Year by year, Total Non-Current Liabilities stood at $46.2 million in 2024, then tumbled by 39.67% to $27.9 million in 2025, then slumped by 32.92% to $18.7 million in 2026.
• Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $18.7 million in Q1 2026, $27.9 million in Q4 2025, and $21.6 million in Q3 2025.